Methoctramine moderately improves memory but pirenzepine disrupts performance in delayed non-matching to position test

被引:28
作者
Aura, J [1 ]
Sirvio, J [1 ]
Riekkinen, P [1 ]
机构
[1] UNIV KUOPIO,AI VIRTANEN INST,FIN-70211 KUOPIO,FINLAND
关键词
muscarinic M-1 receptor; muscarinic M-2 receptor; scopolamine; pirenzepine; methoctramine; (delay-dependent and -independent); (% correct choice); Alzheimer's disease;
D O I
10.1016/S0014-2999(97)01134-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The present study was designed to investigate the effect of i.c.v. administration of various muscarinic receptor antagonists in rats on memory performance in delayed non-matching to position test. The drugs chosen were the non-selective antagonist scopolamine (3 and 10 mu g), the muscarinic M-1 receptor-selective antagonist pirenzepine (10 and 30 mu g) and the muscarinic M-2 receptor-selective antagonist methoctramine (2, 5 and 20 mu g). Scopolamine delay-independently decreased % correct choices and reduced motor activity. Pirenzepine also delay-independently decreased % correct choices. In contrast, methoctramine 2 mu g, but not at 5 or 20 mu g, improved slightly, but significantly, % correct performance delay-dependently. The present data suggests that the decrease in activation of inhibitory muscarinic M-2 autoreceptors induced by methoctramine produces a specific improvement of short-term memory at long forgetting delays. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:129 / 134
页数:6
相关论文
共 28 条
[1]   REVERSAL OF AGE-RELATED COGNITIVE IMPAIRMENTS BY AN M1 CHOLINERGIC AGONIST, AF102B [J].
BRANDEIS, R ;
DACHIR, S ;
SAPIR, M ;
LEVY, A ;
FISHER, A .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1990, 36 (01) :89-95
[2]   AF150(S) - A NEW FUNCTIONALLY SELECTIVE M(1) AGONIST IMPROVES COGNITIVE PERFORMANCE IN RATS [J].
BRANDEIS, R ;
SAPIR, M ;
HAFIF, N ;
ABRAHAM, S ;
OZ, N ;
STEIN, E ;
FISHER, A .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1995, 51 (04) :667-674
[3]   QUANTITATIVE LIGHT MICROSCOPIC AUTORADIOGRAPHIC LOCALIZATION OF CHOLINERGIC MUSCARINIC RECEPTORS IN THE HUMAN-BRAIN - FOREBRAIN [J].
CORTES, R ;
PROBST, A ;
PALACIOS, JM .
NEUROSCIENCE, 1987, 20 (01) :65-107
[4]   MUSCARINIC CHOLINERGIC RECEPTOR SUBTYPES IN THE HUMAN-BRAIN .2. QUANTITATIVE AUTORADIOGRAPHIC STUDIES [J].
CORTES, R ;
PROBST, A ;
TOBLER, HJ ;
PALACIOS, JM .
BRAIN RESEARCH, 1986, 362 (02) :239-253
[5]   MUSCARINIC CHOLINERGIC RECEPTOR SUBTYPES IN THE RAT-BRAIN .1. QUANTITATIVE AUTORADIOGRAPHIC STUDIES [J].
CORTES, R ;
PALACIOS, JM .
BRAIN RESEARCH, 1986, 362 (02) :227-238
[6]  
Dunnett S B, 1990, Neuroreport, V1, P61, DOI 10.1097/00001756-199009000-00017
[8]  
HAGAN JJ, 1987, PSYCHOPHARMACOLOGY, V93, P470
[9]   PIRENZEPINE DISTINGUISHES BETWEEN DIFFERENT SUBCLASSES OF MUSCARINIC RECEPTORS [J].
HAMMER, R ;
BERRIE, CP ;
BIRDSALL, NJM ;
BURGEN, ASV ;
HULME, EC .
NATURE, 1980, 283 (5742) :90-92
[10]   Effects of infusion of cholinergic drugs into the prefrontal cortex area on delayed matching to position performance in the rat [J].
Herremans, AHJ ;
Hijzen, TH ;
Welborn, PFE ;
Olivier, B ;
Slangen, JL .
BRAIN RESEARCH, 1996, 711 (1-2) :102-111